Golden House Ltd (TLV:GOHO)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,103.00
+7.00 (0.64%)
Jul 31, 2026, 11:03 AM IDT
Golden House Market Cap
Golden House has a market cap or net worth of 170.06 million as of July 30, 2026. Its market cap has decreased by -12.67% in one year.
Market Cap
170.06M
Enterprise Value
129.09M
Revenue
46.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,103.00
ChartMarket Cap Chart
Since March 30, 2006, Golden House's market cap has increased from 74.77M to 170.06M, an increase of 127.44%. That is a compound annual growth rate of 4.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 170.06M | 7.24% |
| Dec 31, 2025 | 158.58M | -55.97% |
| Dec 31, 2024 | 360.14M | 47.35% |
| Dec 31, 2023 | 244.41M | 50.96% |
| Dec 29, 2022 | 161.90M | -36.51% |
| Dec 30, 2021 | 255.00M | 16.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 112.49B |
| Danel (Adir Yeoshua) | 2.57B |
| Amal Holdings A.D. | 2.41B |
| BrainsWay | 1.89B |
| Geffen Residence & Renewal | 319.23M |
| Bonus BioGroup | 297.87M |
| InterCure | 151.30M |
| Rekah Pharmaceutical Industry | 124.65M |